|
CIZ1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92109999996859E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31279997983569E-09 |
| Normal-vs-Stage2 |
1.006800E-01 |
| Normal-vs-Stage3 |
1.315400E-01 |
| Normal-vs-Stage4 |
3.871600E-02 |
| Stage1-vs-Stage2 |
1.645990E-02 |
| Stage1-vs-Stage3 |
6.46420000000036E-05 |
| Stage1-vs-Stage4 |
1.124550E-01 |
| Stage2-vs-Stage3 |
6.088400E-01 |
| Stage2-vs-Stage4 |
6.664800E-01 |
| Stage3-vs-Stage4 |
3.276000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5818999999917E-05 |
| Normal-vs-AfricanAmerican |
1.377440E-03 |
| Normal-vs-Asian |
1.165780E-01 |
| Caucasian-vs-AfricanAmerican |
4.317000E-01 |
| Caucasian-vs-Asian |
5.090200E-01 |
| AfricanAmerican-vs-Asian |
7.406000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.753200E-04 |
| Normal-vs-Female |
1.04339999973391E-07 |
| Male-vs-Female |
3.385700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.828500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.85900000013473E-07 |
| Normal-vs-Age(61-80Yrs) |
5.832700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.986800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.649400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.824400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.017400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.132200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.659000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.866400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.713407193904E-12 |
| Normal-vs-Grade 2 |
7.93169996349263E-09 |
| Normal-vs-Grade 3 |
8.100900E-03 |
| Normal-vs-Grade 4 |
2.765600E-01 |
| Grade 1-vs-Grade 2 |
1.66551999999376E-05 |
| Grade 1-vs-Grade 3 |
1.98169999965359E-07 |
| Grade 1-vs-Grade 4 |
2.94069999462465E-08 |
| Grade 2-vs-Grade 3 |
1.182480E-03 |
| Grade 2-vs-Grade 4 |
1.098210E-02 |
| Grade 3-vs-Grade 4 |
5.405400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.03943586649802E-13 |
| Normal-vs-ccB subtype |
4.553400E-01 |
| ccA subtype-vs-ccB subtype |
4.29569713134015E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.843590E-04 |
| Normal-vs-N1 |
2.444400E-01 |
| N0-vs-N1 |
7.893000E-01 |
|
|
